Double outlet left ventricle
disease diseaseOn this page
Also known as DOLVdouble outlet left ventricle (disease)
Summary
Double outlet left ventricle (MONDO:0018090) is a disease. A subtype of conotruncal heart malformations — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 17
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 1 000 000 | 0.5 | Worldwide | Validated |
| Point prevalence | <1 / 1 000 000 | Europe | Not yet validated |
Signs & symptoms
Clinical features (HPO)
17 HPO clinical features (Orphanet curated; top 17 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0011581 | Double outlet left ventricle | Obligate (100%) |
| HP:0001629 | Ventricular septal defect | Very frequent (80-99%) |
| HP:0001643 | Patent ductus arteriosus | Very frequent (80-99%) |
| HP:0033118 | Abnormal right ventricular function | Very frequent (80-99%) |
| HP:0000961 | Cyanosis | Frequent (30-79%) |
| HP:0001640 | Cardiomegaly | Frequent (30-79%) |
| HP:0011662 | Tricuspid atresia | Frequent (30-79%) |
| HP:0011686 | Abnormal coronary artery course | Frequent (30-79%) |
| HP:0000028 | Cryptorchidism | Occasional (5-29%) |
| HP:0000202 | Orofacial cleft | Occasional (5-29%) |
| HP:0000316 | Hypertelorism | Occasional (5-29%) |
| HP:0001508 | Failure to thrive | Occasional (5-29%) |
| HP:0002789 | Tachypnea | Occasional (5-29%) |
| HP:0031664 | Systolic heart murmur | Occasional (5-29%) |
| HP:0004415 | Pulmonary artery stenosis | Very rare (<1-4%) |
| HP:0005182 | Bicuspid pulmonary valve | Very rare (<1-4%) |
| HP:0010882 | Pulmonary valve atresia | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | double outlet left ventricle |
| Mondo ID | MONDO:0018090 |
| Orphanet | 3427 |
| ICD-10-CM | Q20.2 |
| ICD-11 | 2094997989 |
| SNOMED CT | 7368005 |
| UMLS | C0265809 |
| MedGen | 120558 |
| GARD | 0001907 |
| Is cancer (heuristic) | no |
Also known as: DOLV · Double outlet left ventricle · double outlet left ventricle (disease)
Data availability: 1 HPO phenotype.
Disease family
This is a subtype of conotruncal heart malformations. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › congenital anomaly of cardiovascular system › congenital heart malformation › conotruncal heart malformations › double outlet left ventricle
Related subtypes (7): pulmonary atresia with ventricular septal defect, tetralogy of fallot, abnormal origin of the pulmonary artery, congenital aortopulmonary window, persistent truncus arteriosus, double outlet right ventricle, pulmonary valve agenesis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.